Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
and Saeys teams. In this research project you will develop and apply algorithms to link clinical phenotypes of metastasis to molecular phenotypes in mouse models. It is known that metastases exhibit
-
the Guilliams and the Saelens team. Research Project In this research project you will apply in vivo CRISPR screens to study the functional specialization of liver macrophages. This project is supported by an ERC
-
supported by a Foundation against Cancer (2025 – 2030). We have developed in vivo single-cell CRISPR technologies to screen for dozens of molecular factors in tumor-associated macrophages (TAMs) in vivo. We
-
change in identity in all other cells, often resulting in molecular states that are eerily similar to those observed in diseases. How these intercellular cascades are exactly wired is poorly understood
-
the Guilliams and the Saelens team. Research Project In this research project you will apply in vivo CRISPR screens to study the molecular mechanisms driving liver regeneration. This project is supported by
-
VIB CMN is seeking a part-time, (Junior) Linux System Administrator to join our IT team. We’re looking for someone with hands-on Linux administration skills, a strong interest in security, and
-
initiative investigating how human-specific features of brain development shape early behavior and neural circuit function in autism spectrum disorders (ASD). This position is a joint effort between the
-
central goal is to understand how these effects are shaped by human-specific SRGAP2 genes, which regulate synaptic timing via SYNGAP1. To achieve this, we will use: Xenotransplantation models of human
-
, industrial and medical applications and new innovative biotech companies. The Laboratory for Genome Editing and System Genetics at CfM combines development of high-throughput genome editing tools with large
-
, industrial and medical applications and new innovative biotech companies. The Laboratory for Genome Editing and System Genetics at CfM combines development of high-throughput genome editing tools with large